Resmed Inc. buy UBS Group AG
Start price
01.08.25
/
50%
€241.30
Target price
01.08.26
€284.77
Performance (%)
-11.98%
Price
27.01.26
€212.40
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.98%. This prediction currently runs until 01.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -1.667% | -1.667% |
| iShares Core DAX® | 1.130% | 2.184% |
| iShares Nasdaq 100 | 1.128% | -0.611% |
| iShares Nikkei 225® | 2.610% | 4.958% |
| iShares S&P 500 | -0.006% | -0.952% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at UBS Group AG from $285.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat